Every Form 4 that Innoviz Technologies Ltd (INVZ) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow INVZ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INVZ filings page.
Innoviz Technologies Ltd. reported a compensation grant to director Har Even Yoav of 90,162 Restricted Share Units (RSUs) on August 4, 2026. The RSUs will fully vest on April 5, 2027, if he remains a service provider at that date. Each RSU represents a contingent right to receive one ordinary share, with no exercise price, and 90,162 ordinary shares are reported as directly held following this grant.
Innoviz Technologies reported that Chief Operating Officer Ido Luski received new equity awards on August 4, 2026. He was granted 64,688 Restricted Share Units and share options for 69,296 ordinary shares at a 0.4200 per-share exercise price, both vesting one-fourth on August 4, 2027 and quarterly thereafter through 2030, subject to continued service. Following these awards, he directly owns 393,701 ordinary shares, including shares underlying RSUs.
Innoviz Technologies Chief Financial Officer Eldar Mordechay Cegla reported equity compensation grants dated August 4, 2026. He received 78,416 share options with a $0.42 exercise price expiring on August 4, 2033 and 73,184 RSUs, both vesting one-fourth on August 4, 2027 with the remainder vesting quarterly through 2030, subject to continued service. After these awards, he is reported as holding 537,237 ordinary shares, including 234,628 shares issuable upon vesting of RSUs.
Innoviz Technologies Ltd. granted Chief Business Officer Elad Ben Hofstetter 57,968 share options on August 4, 2026, each for one ordinary share at an exercise price of $0.42 per share. These options vest one-fourth on August 4, 2027, with the remainder vesting quarterly through 2030, and expire on August 4, 2033.
The company also granted 54,112 Restricted Share Units (RSUs), each a contingent right to one ordinary share with no exercise price, vesting on the same schedule and subject to continued service. After these awards, he directly holds 286,256 ordinary shares, including 176,964 shares issuable upon vesting of multiple RSU grants.
Innoviz Technologies Ltd. reported equity awards to Chief R&D Officer Avishay Ben Moscovici on August 4, 2026. He received 71,072 share options for ordinary shares with a 0.4200 per share exercise price, expiring on 2033-08-04, and 66,336 Restricted Share Units (RSUs). Both the options and RSUs vest one-fourth on August 4, 2027, with the remainder vesting quarterly through 2030, subject to his continued service. After these grants, he reported 397,001 ordinary shares, including 213,724 shares issuable upon RSU vesting, and 71,072 share options.
Innoviz Technologies Ltd. director and Chief Executive Officer Omer David Keilaf reported a non-market reallocation of his holdings tied to a divorce settlement. He transferred 679,400 ordinary shares and options to purchase an additional 907,511 ordinary shares to his former spouse, Gali Moscovici, for no consideration. Following the transfer, he directly holds 2,826,531 ordinary shares, plus remaining share options and restricted share units that continue to vest over several years, subject to his continued service with the company.
Innoviz Technologies director Stefan Jacoby received an equity grant of 110,668 Restricted Share Units (RSUs). The RSUs were granted on May 13, 2026 and will fully vest on April 5, 2027, if he remains a service provider. Each RSU converts into one ordinary share, bringing his direct holdings to 291,994 ordinary shares and RSUs, including 181,326 ordinary shares.
Innoviz Technologies Ltd. director Ronit Maor Shenaar received an equity grant in the form of restricted share units. The filing reports an award of 110,668 Ordinary Shares at a price of $0.00 per share, increasing direct holdings to 344,997 ordinary shares.
According to the footnotes, the grant consists of 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which will fully vest on April 5, 2027, provided the director remains a service provider to Innoviz through that date. Each RSU represents a contingent right to receive one ordinary share with no exercise price. The filing also notes that the reported post-transaction position includes 234,329 ordinary shares in addition to the new RSUs.
Innoviz Technologies Ltd. director Orit Stav reported a compensation-related equity grant. On May 13, 2026, Stav received 110,668 Restricted Share Units (RSUs), each representing a contingent right to one ordinary share, with no exercise price. These RSUs are scheduled to fully vest on April 5, 2027, if Stav remains a service provider through that date. Following this award, Stav directly holds 344,997 ordinary shares, which includes 234,329 already-issued ordinary shares.
Innoviz Technologies Ltd. director James J. Sheridan III reported an equity compensation grant rather than an open‑market trade. He received 110,668 Restricted Share Units (RSUs) on May 13, 2026, each representing one ordinary share, with no exercise price. These RSUs fully vest on April 5, 2027, if he remains a service provider. Following the grant, his reported holdings total 427,397 ordinary shares, including 234,329 shares held directly and 82,400 shares held by Perception Capital Partners, LLC, where he may be deemed a beneficial owner.
Innoviz Technologies Ltd. director Dan Michael Falk reported an equity compensation grant of 110,668 Restricted Share Units (RSUs) on May 13, 2026. Each RSU represents a contingent right to receive one ordinary share with no exercise price.
The RSUs will fully vest on April 5, 2027, provided Falk remains a service provider to Innoviz through that date. Following this award, he holds 344,997 ordinary shares in total, which includes 234,329 ordinary shares already owned.
Innoviz Technologies Ltd. director Amichai Steimberg received an equity award of 265,602 Restricted Share Units (RSUs) on May 13, 2026. Each RSU represents a contingent right to one ordinary share and has no exercise price.
The RSUs will fully vest on April 5, 2027, if he continues as a service provider through that date. Following this grant, Steimberg directly holds 989,336 ordinary shares, which includes 723,734 ordinary shares already held.
Von Witzleben Alexander Reymar Karl-Wilhelm reported acquisition or exercise transactions in this Form 4 filing.
Innoviz Technologies director Alexander Reymar Karl-Wilhelm Von Witzleben received a compensation-related grant of 110,668 Restricted Share Units on May 13, 2026. These RSUs will fully vest on April 5, 2027, if he remains a service provider. After the grant, he holds 296,768 ordinary shares, including 186,100 ordinary shares.
Innoviz Technologies Ltd. director Aharon Aharon received a compensation grant of 110,668 Restricted Share Units (RSUs) on May 13, 2026. Each RSU gives the right to one ordinary share with no exercise price, so there is no cash paid to acquire these shares.
The RSUs will fully vest on April 5, 2027, if he remains a service provider to the company on that date. After this grant, he directly holds 344,997 ordinary shares, including 234,329 ordinary shares already held before this award.
Innoviz Technologies Ltd. Chief Executive Officer Omer Keilaf reported an internal share transfer rather than a market trade. He moved 723,019 ordinary shares to his former spouse, Ms. Gali Moscovici, as part of a divorce settlement, with no price per share reported.
After this transfer, Keilaf is shown with 3,505,931 ordinary shares, including 1,135,780 ordinary shares issuable upon vesting of restricted share units, which vest in scheduled quarterly installments through various dates from 2026 to 2029, subject to his continued service with the company.